Abstract: The present disclosure describes techniques that may provide more accurate estimates of arterial oxygen saturation using pulse oximetry by switching between a wavelength spectrum of at least a first and a second light source so that the arterial oxygen saturation estimates at low (e.g., in the range below 75%), medium (e.g., greater than or equal to 75% and less than or equal to 84%), and high (e.g., greater than 84% range) arterial oxygen saturation values are more accurately calculated. In one embodiment, light emitted from a near 660 nm and a near 900 nm emitter pair may be used when the arterial oxygen saturation range is high. In another embodiment, light emitted from a near 730 nm and a near 900 nm emitter pair may be used when the arterial oxygen saturation range is low. In yet another embodiment, light emitted from both a near 660 nm-900 nm emitter pair and light emitted from a near 730 nm-900 nm emitter pair may be used when the arterial oxygen saturation range is in the middle range.

Abstract: A method and system for controlling a ventilator is disclosed. Oxygen saturation values from pulse oximeters may be used to adjust the settings of a ventilator. Multiple sensors and multiple oxygen saturation values in a fault tolerant pulse oximeter configuration may be used to provide a backup value or confidence measure, thereby increasing reliability and patient safety.

Abstract: According to various embodiments, a medical sensor assembly may include compressible light barriers configured to prevent undesired light from being detected. The compressible light barriers may protrude from the surface of the sensor. However, when applied to the tissue, the compressible light barriers may be compressed to the point of being substantially flush with the tissue.

Abstract: Methods and systems are provided that allow for the simultaneous calculation of pulse and regional blood oxygen saturation. An oximeter system that includes a sensor with a plurality of emitters and detectors may be used to calculate a pulse and/or regional blood oxygen saturation. A plurality of light signals may be emitted from light emitters. A first light signal may be received at a first light detector and a second light signal may be received at a second light detector. A pulse and/or regional blood oxygen saturation value may be calculated based on the received first and/or second light signals. The pulse and regional blood oxygen saturation values may be calculated substantially simultaneously. The calculated pulse and regional blood oxygen saturation values as well as other blood oxygen saturation values may be displayed simultaneously in a preconfigured portion of a display.

Abstract: A physiological sensor includes an emitter configured to transmit light and a detector configured to receive the transmitted light. The sensor also includes a first accelerometer disposed on a first portion of the sensor and a second accelerometer disposed on a second portion of the sensor, the second portion opposing the first portion. The first and second accelerometers are configured to measure a change in motion that corresponds to a change in distance between the detector and the emitter.

Abstract: Embodiments of the present disclosure relate to patient monitors with alarm modeling features that may be employed to set alarm limits. According to certain embodiments, the patient monitors may include a user interface for setting alarm limits that may be displayed on the patient monitors and/or on an external device, such as a central monitoring station. The user interface may allow a user to vary alarm limit settings and view how the settings change the alarm history for a representative data trend.

Abstract: In some embodiments, systems and methods for identifying a low perfusion condition are provided by transforming a signal using a wavelet transform to generate a scalogram. A pulse band and adjacent marker regions in the scalogram are identified. Characteristics of the marker regions are used to detect the existence of a lower perfusion condition. If such a condition is detected, an event may be triggered, such as an alert or notification.

Abstract: According to various embodiments, a tracheal tube may employ optical sensing techniques for determining a distance between the inserted tube and an anatomical structure such as a carina. The distance information may provide an indication as to whether or not the tracheal tube is properly placed within the trachea. The optical techniques may include interferometry.

Abstract: According to various embodiments, a tracheal tube may employ optical sensing techniques for determining a distance between the inserted tube and an anatomical structure, such as a carina. The distance information may provide an indication as to whether or not the tracheal tube is properly placed within the trachea. The optical techniques may include time of flight techniques.

Abstract: According to embodiments, systems, devices, and methods for biological sensing with laser self-mixing sensors are disclosed. In one embodiment, one or more self-mixed laser Doppler signals may be used to detect blood flow velocity or blood vessel wall velocity. In one embodiment, a blood vessel wall compliance may be derived from the blood vessel wall velocity. In one embodiment, blood pressure may be calculated based at least in part on blood flow velocity or based at least in part on blood flow velocity and blood vessel compliance. In one embodiment, common mode noise may be removed from one or more laser signals.

Abstract: According to various embodiments, a medical sensor assembly may include compressible light barriers configured to prevent undesired light from being detected. The compressible light barriers may protrude from the surface of the sensor. However, when applied to the tissue, the compressible light barriers may be compressed to the point of being substantially flush with the tissue.

Abstract: Present embodiments are directed to a system and method capable of modulating light to at least one modulation frequency selected based on at least one blood parameter of a medium being monitored to generate photon density waves in a medium, detecting relative amplitude changes and phase shifts in the photon density waves, and determining at least one blood parameter related to scattering particles in the medium based on the phase shifts.

Abstract: Multi-wavelength photon density wave medical systems, methods, and devices are provided. In one embodiment, a multi-wavelength photon density wave patient monitor includes multiple light sources, a driving circuit, a fiber coupler, a sensor cable connector, a wavelength demultiplexer, detectors, and data processing circuitry. The driving circuit may modulate the light sources to produce several single-wavelength input photon density wave signals, which the fiber coupler may join into a multi-wavelength input signal. The sensor cable connector may provide this multi-wavelength input signal to a sensor attached to the patient and receive a multi-wavelength output signal. The wavelength demultiplexer may separate the multi-wavelength output signal into single-wavelength output signals for detection by the detectors.

Abstract: A system and method for compensating for movement in a sensor. A sensor may include an emitter configured to transmit light, a detector configured to receive the transmitted light via a respective light path, and an accelerometer configured to measure a change in distance between the detector and the emitter. The sensor may transmit the measurements relating to the change in distance between the detector and the emitter to a pulse oximetry monitor. The pulse oximetry monitor may generate an attenuation factor corresponding to the change in the distance between the detector and the emitter that may be used to compensate for movement in a sensor when calculating physiological parameters of a patient.

Abstract: Present embodiments are directed to a monitor system, such as a pulse oximetry system. The system may include a detection feature, an emission feature capable of emitting light into tissue and arranged relative to the detection feature such that the detection feature is capable of detecting the light from the tissue after passing generally through a portion of the tissue, a modulator capable of modulating the light to generate photon density waves at a modulation frequency generally in a range of 50 MHz to 3 GHz, a detector communicatively coupled with the detection feature, wherein the detector is capable of detecting characteristics of the photon density waves comprising amplitude changes and phase shifts, and a processor capable of making determinations relating to a value of a physiologic parameter of the tissue based at least in part on the detected characteristics.

Abstract: In some embodiments, systems and methods for identifying a low perfusion condition are provided by transforming a signal using a wavelet transform to generate a scalogram. A pulse band and adjacent marker regions in the scalogram are identified. Characteristics of the marker regions are used to detect the existence of a lower perfusion condition. If such a condition is detected, an event may be triggered, such as an alert or notification.

Abstract: Nanofiber adhesives and their uses with device, such as medical devices, are described. In one embodiment, a nanofiber adhesive layer may be disposed on a surface of a medical device, such as a backing layer of a sensor, for adhesion to a substrate. The nanofiber adhesive layer may allow durable adhesion to the substrate. Other described features may include materials and methods to determine the attachment of the medical device to a patient by determining the adhesive state of the adhesive layer.

Abstract: According to embodiments, a medical sensor may be configured for use on mucosal tissue. Such a sensor may include a portion that facilitate the application of the sensor to the tissue and a portion that includes the optical components of the sensor. The two portions of the sensor may be reversibly coupled to one another. In embodiments, such sensors may be used to determine patient hematocrit.

Abstract: A sensor assembly and/or systems for bioimpedance measurements may provide information related to the lean body water of the patient's tissue. The information related to the patient's lean body water may be determined by spectroscopic methods for determining water fraction. The patient's fat-free hydration levels may be incorporated into determinations of physiological parameters that may be determined by bioimpedance, such as cardiac output, hemtocrit, or body fat percentage.

Abstract: A monitoring system that may include an emission feature capable of emitting light into tissue, a modulator capable of modulating the emitter at a modulation frequency generally in a range of about 50 MHz to 3.0 GHz to generate resolvable photon density waves, a detection feature capable of detecting photons of the photon density waves after passage through the tissue and capable of providing a distribution of detected photons over a time period for the photon density waves, and a processor capable of calculating a skewness of the distribution and making determinations relating to a value of a physiologic parameter of the tissue based at least in part on the skewness of the distribution.